Regulus Therapeutics Inc. (RGLS) Deferred Income Tax Expense (Benefit) USD 2010 - 2023

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary: Regulus Therapeutics Inc. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
Regulus Therapeutics Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2013 was -$10 K.
Regulus Therapeutics Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $0.000.
Regulus Therapeutics Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $0.000.
Regulus Therapeutics Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $0.000, a 100% decline from 2020.

Deferred Income Tax Expense (Benefit), Annual (USD)

Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	$0	$0		Jan 1, 2023	Dec 31, 2023	10-K	2024-03-21
2022	$0	$0		Jan 1, 2022	Dec 31, 2022	10-K	2024-03-21
2021	$0	-$12 K	-100%	Jan 1, 2021	Dec 31, 2021	10-K	2023-03-23
2020	$12 K	-$1 K	-7.69%	Jan 1, 2020	Dec 31, 2020	10-K	2022-03-11
2019	$13 K	-$74 K	-85.1%	Jan 1, 2019	Dec 31, 2019	10-K	2021-03-09
2018	$87 K	+$142 K		Jan 1, 2018	Dec 31, 2018	10-K	2020-03-12
2017	-$55 K	-$50 K	-1000%	Jan 1, 2017	Dec 31, 2017	10-K	2019-03-18
2016	-$5 K	+$14 K	+73.7%	Jan 1, 2016	Dec 31, 2016	10-K	2019-03-18
2015	-$19 K	-$19 K		Jan 1, 2015	Dec 31, 2015	10-K	2018-03-08
2014	$0	+$24 K		Jan 1, 2014	Dec 31, 2014	10-K	2017-03-03
2013	-$24 K	-$13 K	-118%	Jan 1, 2013	Dec 31, 2013	10-K	2016-02-23
2012	-$11 K			Jan 1, 2012	Dec 31, 2012	10-K	2015-02-19
2010	$394 K			Jan 1, 2010	Dec 31, 2010	10-K	2013-02-19

* An asterisk sign (*) next to the value indicates that the value is likely invalid.